Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007178 220002803 0 71 Not known (9) 2015-03-31 2015-04-03 IDARUBICIN + TRETINOIN Y N 220031857 IDARUBICIN + TRETINOIN
220007179 220002804 0 87.7 Curative (C) 2017-01-15 2017-01-25 AML 18 Pilot Trial N N 220031869 PILOT TRIAL
220007180 220002804 1.52 null Palliative (P) 2015-03-18 2015-03-23 Dasatinib 02 N 220031869 DASATINIB
220007181 220002804 1.63 76 Curative (C) 2015-08-25 2015-09-07 AML16 DA 2+5 N N 220031869 AML16 TRIAL
220007182 220002804 1.81 89.9 Palliative (P) 2014-04-19 2014-04-30 Dasatinib 2 N 220031869 DASATINIB
220007183 220002805 1.76 null Palliative (P) 2017-02-09 2017-02-09 IDARUBICIN + TRETINOIN N N 220031880 IDARUBICIN + TRETINOIN
220007185 220002807 1.79 null Curative (C) 2014-08-31 2014-09-08 AML16 DA 3+10 N N 220031885 AML16 TRIAL
220007186 220002807 1.68 null Curative (C) null 2017-01-18 AML 18 TRIAL 01 N 220031885 AML18 TRIAL
220007187 220002807 1.82 79 Palliative (P) 2015-02-07 2015-02-27 Carboplatin + Paclitaxel (3 weekly) 2 N 220031885 CARBOPLATIN + PACLITAXEL
220007188 220002807 1.82 null Palliative (P) 2016-11-15 2016-11-29 CARBOPLATIN + GEMCITABINE N null 220031885 GEMCARBO
220007189 220020408 1.75 null Curative (C) 2013-06-21 2013-06-29 AML18 PILOT TRIAL 1 N 220031893 PILOT TRIAL
220007193 220002808 1.63 null Palliative (P) 2016-10-13 2016-11-04 Carboplatin + Paclitaxel (3 weekly) 02 N 220031898 CARBOPLATIN + PACLITAXEL
220007194 220002809 1.79 133.4 null 2015-02-14 2015-02-14 AML16 Low Dose Cytarabine N N 220031899 AML16 TRIAL
220007195 220002809 1.56 null Curative (C) null 2015-06-08 AML18 PILOT TRIAL Y N 220031899 PILOT TRIAL
220007196 220002809 null 76 null 2014-11-26 2014-11-26 CISPLATIN + GEMCITABINE 02 N 220031899 CISPLATIN + GEMCITABINE
220007197 220002809 1.68 59.8 null null 2016-09-06 AML16 Low Dose Cytarabine N N 220031899 AML16 TRIAL
220007198 220002810 1.83 75.6 Palliative (P) 2014-11-21 2014-11-21 Cisplatin + Gemcitabine (D 1 & 8) N null 220031908 CISPLATIN + GEMCITABINE
220007199 220002811 1.6 50 Palliative (P) null 2013-05-10 Carboplatin + Paclitaxel (3 weekly) N N 220031909 CARBOPLATIN + PACLITAXEL
220007200 220002812 0 null Palliative (P) 2016-05-20 2016-06-24 Carboplatin + Paclitaxel (3 weekly) 2 N 220031910 CARBOPLATIN + PACLITAXEL
220007201 220002812 1.67 86.3 Disease modification (D) 2016-06-06 2016-06-06 Dasatinib 2 null 220031910 DASATINIB
220007202 220002813 1.67 82.1 Palliative (P) 2017-01-13 2017-04-29 GemCarbo Days 1+8 N N 220031912 GEMCARBO
220007203 220002814 null 85.2 Curative (C) 2014-02-19 2014-03-05 AML 18 TRIAL Y N 220031916 AML18 TRIAL
220007204 220011602 1.6 79 Palliative (P) 2014-07-06 2014-07-06 GemCarbo Days 1+8 N N 220031919 GEMCARBO
220007205 220002815 1.52 null Palliative (P) 2015-02-04 2015-02-05 GEMCARBO 02 N 220031920 GEMCARBO
220007206 220002815 1.7 83.3 Palliative (P) null 2016-07-18 Carboplatin + Paclitaxel (3 weekly) N N 220031920 CARBOPLATIN + PACLITAXEL
220007207 220002816 1.55 53 null 2014-11-13 2014-11-18 GemCarbo Days 1+8 N N 220031922 GEMCARBO
220007208 220002816 1.87 128 Curative (C) null 2014-08-09 Carboplatin + Paclitaxel (3 weekly) N null 220031922 CARBOPLATIN + PACLITAXEL
220007209 220016243 1.67 80.9 Curative (C) 2013-08-08 2013-08-08 Idarubicin+Tretinoin Spanish Crse1 02 N 220031924 IDARUBICIN + TRETINOIN
220007210 220002817 1.82 null Palliative (P) 2013-12-23 2013-12-28 GemCarbo Days 1+8 null N 220031925 GEMCARBO
220007211 220011605 1.54 null Palliative (P) 2016-10-04 2017-11-08 Dasatinib 2 N 220031929 DASATINIB
220007212 220011605 null 125 Curative (C) 2017-01-08 2017-01-11 AML18 PILOT TRIAL N N 220031929 PILOT TRIAL
220007213 220011605 1.77 89.6 Curative (C) 2016-03-19 2016-03-19 AML18 PILOT TRIAL Y N 220031929 PILOT TRIAL
220007214 220011605 1.6 87.5 Curative (C) 2017-03-04 2017-03-05 AML 18 TRIAL 01 N 220031929 AML18 TRIAL
220007215 220011605 1.65 97.5 null 2016-10-03 2016-10-03 CISPLATIN + GEMCITABINE 02 N 220031929 CISPLATIN + GEMCITABINE
220007218 220002819 1.64 63.4 Curative (C) 2018-07-17 2018-07-17 Dasatinib N N 220031943 DASATINIB
220007219 220002819 1.59 45.8 null 2014-04-29 2014-04-30 Dasatinib 2 N 220031943 DASATINIB
220007221 220002821 1.69 96.4 Disease modification (D) 2017-01-14 2017-01-21 AML16 DA 3+10 N N 220031947 AML16 TRIAL
220007222 220011607 1.77 90 Curative (C) 2014-08-01 2014-08-02 IDARUBICIN + TRETINOIN 2 N 220031948 IDARUBICIN + TRETINOIN
220007223 220002822 1.6 87 Palliative (P) 2017-11-28 2018-01-02 Carboplatin + Paclitaxel (3 weekly) N N 220031949 CARBOPLATIN + PACLITAXEL
220007224 220002823 1.71 95 Curative (C) 2014-10-18 2014-10-22 IDARUBICIN + TRETINOIN 02 N 220031952 IDARUBICIN + TRETINOIN
220007225 220002824 1.86 71 Curative (C) 2014-12-02 2014-12-02 Idarubicin+Tretinoin Spanish Crse1 null N 220031953 IDARUBICIN + TRETINOIN
220007226 220002825 1.64 47.5 Palliative (P) 2016-01-26 2016-02-08 CARBOPLATIN + PACLITAXEL N N 220031957 CARBOPLATIN + PACLITAXEL
220007228 220002826 1.84 null Palliative (P) 2016-02-04 2016-02-04 Dasatinib N N 220031961 DASATINIB
220007229 220002826 0 62.2 Curative (C) null 2013-06-22 AML18 PILOT TRIAL Y N 220031961 PILOT TRIAL
220007230 220002826 0 99.6 Palliative (P) 2014-05-31 2014-06-05 GEMCARBO N N 220031961 GEMCARBO
220007231 220002827 1.76 80 Curative (C) 2014-10-06 2014-10-06 AML16 Low Dose Cytarabine N null 220031967 AML16 TRIAL
220007232 220002827 0 0 Neo-adjuvant (N) 2013-01-25 2013-02-17 CARBOPLATIN + PACLITAXEL 02 N 220031967 CARBOPLATIN + PACLITAXEL
220007233 220002827 1.7 79.5 Curative (C) null 2015-06-15 Idarubicin+Tretinoin Spanish Crse1 N N 220031967 IDARUBICIN + TRETINOIN
220007234 220018890 1.82 93.1 Curative (C) 2014-02-18 2014-02-23 AML 18 TRIAL 01 N 220031971 AML18 TRIAL
220007235 220018890 null 67 Curative (C) 2017-06-13 2017-06-13 IDARUBICIN + TRETINOIN Y N 220031971 IDARUBICIN + TRETINOIN